 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
• |
ONDCP
|
|
|
|
– |
1.
Drug Cabinet Council meeting 12/12, issue on the agenda
|
|
|
|
– |
2.
Funding for medical research literature review
|
|
|
|
– |
3.
Lead government’s message development
|
|
|
|
– |
4.
Model State Drug Law Alliance monitoring and development of
|
|
|
laws
with national strategy
|
|
|
|
– |
5.
Assist in developing medical information clearing house
|
|
|
|
– |
6.
Determine what impact the initiatives have on federal funding to
|
|
states
which do not cooperate in a national drug strategy
|
|